Research

Mixed

Inducing senescence in cancer cells (prosenescence) followed by senolytic clearance ('one-two punch') or immune potentiation can improve cancer treatment outcomes by exploiting vulnerabilities of senescent tumor cells.

For cancer patients, combining standard treatments with senolytics is a promising strategy being studied in labs. It aims to kill cancer cells and then clear the remaining damaged ones. This is not yet a standard of care.

ModerateSupportsMEDIUM confidence
One way to potentiate anticancer therapies is to pair them with senolytic treatments. This strategy of following up prosenescence treatment with senolytics has been termed a 'one–two punch approach'...
Jodie Birch et al. · Genes & Development · 2020

Why this rating

Preclinical success in mouse models; human trials are still needed.

Source

Senescence and the SASP: many therapeutic avenues

Jodie Birch et al. · Genes & Development · 2020

DOI 10.1101/gad.343129.120

narrative_reviewCited 1,104×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →